findmyKOL

Stephen Silberstein, MD

Enriched profile

Professor Emeritus, Department of Neurology, Thomas Jefferson University (Sidney Kimmel Medical College) · Thomas Jefferson University

ORCIDNPI
Region🇺🇸 Philadelphia, PA · Northeast · United StatesSpecialtyNeurologyFocusMigraine and Headache Studies+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Stephen Silberstein is Professor Emeritus, Department of Neurology, Thomas Jefferson University (Sidney Kimmel Medical College) at Thomas Jefferson University. OpenAlex indexes 146 publications with 4,685 citations (h-index 33); ClinicalTrials.gov lists 14 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Stephen Silberstein, M.D., is Professor Emeritus, Department of Neurology, Thomas Jefferson University (Sidney Kimmel Medical College). The public record shows 146 publications with 4,685 citations (h-index 33), centered on Migraine and Headache Studies, Neurological Complications and Syndromes, Trigeminal Neuralgia and Treatments. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 27 companies.

  • Most recent indexed publication: 2026 · Expert review of neurotherapeutics
  • Top research focus: Migraine and Headache Studies
  • 14 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 27 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Migraine / Headache13 trialsPain6 trialsHeadache6 trialsCluster Headache1 trialForamen Ovale, Patent1 trialHeadache Disorders1 trialNeuralgia1 trialTrigeminal Neuralgia1 trial

Research focus

OpenAlex concept fingerprint
Migraine and Headache StudiesNeurological Complications and SyndromesTrigeminal Neuralgia and TreatmentsNeuroscience and Neuropharmacology ResearchSympathectomy and Hyperhidrosis Treatments

Drugs & molecules

across trials, industry payments and publications
Trudhesageneric · DihydroergotamineClinical trialsIndustry payments23Publications1Quliptageneric · AtogepantClinical trialsIndustry payments18Publications2Ubrelvygeneric · UbrogepantClinical trialsIndustry payments16Publications1

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trialsIndustry payments53Impel Pharmaceuticals Inc.Clinical trialsIndustry payments23Teva Pharmaceuticals USA, Inc.Clinical trialsIndustry payments16

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
146publications

Distinct works indexed by OpenAlex, matched via ORCID; 27 in PubMed.

4,685citations

Total citations across indexed works.

33h-index

Hirsch index (OpenAlex). i10-index 51.

Clinical & industry

trials, payments and federal funding
14clinical trials

Investigator role on registered studies.

View trials
27companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

27 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    100%
    Calcitonin gene-related peptide (CGRP) antagonists60%
    Emgality Pen100%
    Part D<11 patients
    Other antiepileptics40%
    Topiramate100%
    Part D<11 patients
Where care is delivered (Part B), 2021100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/stephen-silberstein-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/stephen-silberstein-723b8719

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • Other

    profiles.jefferson.edu/display/32816

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.jefferson.edu
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/neurologylive/posts/stephen-d-silberstein-md-director-of-the-headache-center-at-jefferson-university/1047387019398551

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • Instagram

    instagram.com/p/CxD2S-9xR26

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
  • Other

    migraineworldsummit.com/expert/stephen-silberstein-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →migraineworldsummit.com
3 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    University of Pennsylvania School of Medicine (residency at Hospital of the University of Pennsylvania; fellowship at NIH)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu
  • Board certified

    American Board of Psychiatry and Neurology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu
  • Subspecialty certification

    Headache Medicine, United Council for Neurologic Subspecialties

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu

Editorial & leadership roles

journal and society appointments
  • Editorial Board member

    CGRP Education & Research Forum

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cgrpforum.org
  • Past President

    Treasurer, and Board of Directors member, American Headache Society

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jefferson.edu
  • Founding Director

    Jefferson Headache Center (now Professor Emeritus; current division chief is Michael J. Marmura, MD)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jefferson.edu
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Fellow

    American College of Physicians; Fellow, American Academy of Neurology; Member, American Neurological Association

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com

Media & interviews

press, podcasts and appearances
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.